Drinker Biddle & Reath LLP
HBM variants that modulate bone mass and lipid levels
The present invention relates to methods and materials used to express an HBM-like polypeptide derived from HBM, LRP5 or LRP6 in animal cells and transgenic animals. The present invention also relates to transgenic animals expressing the HBM-like polypeptides. The invention provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development and lipid modulation. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
Wyeth Oscient Pharmaceuticals Corporation
A A A A C A A A C A A C G A G C A C C A C A A C A A A C A A A C
A01K A01K A61P A61P C07K A61P A61P A61K C12N A01K A61P C12N G01N A01K G01N C12N A01K C12N C12N A61P C12N A61P A01K C12N A01K A61P A01K C07K A01K A01K A01K C12N
additional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional additional additional additional additional additional additional additional additional inventional additional inventional additional additional additional inventional additional inventional additional additional additional additional
James R. Kristina Paul J. Wei Arturo Anthony
Graham Allen Yaworsky Liu Morales Anisowicz